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Objectives
To investigate that the treatment of the hemofiltration
combine with HA hemoadsorption to improve the
immune function in HLA-DR low expression of sepsis
patients.
Methods
60 sepsis patients with HLA -DR expression < 30% of
patients was selected, and divided them randomly into
experimental group and control group, each group has
30 cases, and they were treated with sepsis standard
operating procedures, on the basis of that, the experi-
mental group increases the treatment of hemofiltration
combine with the HA hemoadsorption in 1-3 days, the
CVVH mode, and the former dilution volume is 4L/h,
the hemofilter HF2000 series blood adsorber HA -330H.
On the 0, 3, 5, 7 days of treatment, detecting the two
groups of patients’ expression level of the peripheral
blood mononuclear cells of HLA - DR; and evaluate
APACHE II scores of two groups of patients, duration
of mechanical ventilation, ICU stay and the differences
of 28 days survival rate between the two groups.
Results
Patients’ HLA-DR expression of two groups was all < 30%
before treatment, and there is no statistical difference,
(25.9 ± 7.3% vs 26.4 ± 6.7%, p > 0.05). In the treatment of
3, 5, 7 days ,the HLA - DR expression of the experimental
group increased significantly, and apparently higher than
the control group, there are statistical differences, includ-
ing after the treatment 3 days that HLA - DR (38.9 ± 8.6%
vs 29.3 ± 7.1%, P < 0.05), 5 days’ (42.7 ± 9.2% vs 31.4 ±
6.5%, P < 0.05), 7 days’ (40.9 ± 8.5% vs 29.4 ± 6.7%,
P < 0.05). APACHE II grade shows that there is no
significant difference between the two groups before
treatment (22.4 ± 5.3 vs 21.7 ± 6.2, P > 0.05). After 3,5,
and 7 days’ treatment, we can see the APACHE II grade
of the experimental group decreased, which is obviously
less than the control group, and there is statistical dif-
ference between two groups. The APACHE II grade
after 3 days treatment is (18.6 ± 3.6 vs 20.5 ± 4.3, p <
0.05), 5 days’ treatment is (15.8 ± 3.9 vs 21.1 ± 4.4, p <
0.05) and 7 day’ treatment is (14.9 ± 4.2 vs 19.8 ± 3.7, p
< 0.05). Comparing the experimental group to the con-
trol group, there is a statistical difference in the duration
of mechanical ventilation (13.3 ± 3.4 vs 18.9 ± 4.5, P <
0.05), ICU stay (20.7 ± 3.9 vs 26.8 ± 4.7, P < 0.05) and
the 28 days survival rate (83.3% vs 73.3%, P < 0.05).
Conclusions
Hemofiltration combined with HA hemoadsorption can
improve the expression level of HLA-DR low expression
of sepsis patients, to some degree ,improve immune
function of sepsis patients and prognosis.
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